Chersi A, Schulz G, Houghten R A
Mol Immunol. 1984 Oct;21(10):847-52. doi: 10.1016/0161-5890(84)90138-x.
Three peptides selected from the amino acid sequence of the alpha- and beta-chains of DR2 histocompatibility antigens were chemically synthesized and coupled to carrier proteins to be used as immunogens in rabbits. This immunization resulted in the production of specific antibodies that readily recognized the antigen. However, only one of the four antibody preparations, antibody 6148, elicited by a short peptide from the beta-chain (residues 61-73), reacts with native membrane glycoproteins as well as intact human lymphoblastoid cells in enzyme-linked immunosorbant assays. This antibody was found to react also with membrane glycoproteins solubilized by nonionic detergents from cells bearing a different HLA-DR specificity: therefore it is likely that the peptide responsible for eliciting antibody 6148 represents a common framework determinant of DR alloantigens that is accessible on the surface of lymphoblastoid cells. The ability of antibody 6148 to bind to intact cells was confirmed by indirect immunofluorescence and by fluorescein-activated cell sorter analysis. This antibody is also capable of mediating antibody-dependent cellular cytotoxicity as determined by a 51Cr-release assay.
从DR2组织相容性抗原的α链和β链氨基酸序列中选出三种肽进行化学合成,并与载体蛋白偶联,用作兔免疫原。这种免疫产生了能轻易识别该抗原的特异性抗体。然而,在由β链(第61 - 73位氨基酸残基)的短肽引发产生的四种抗体制剂中,只有抗体6148在酶联免疫吸附测定中能与天然膜糖蛋白以及完整的人淋巴母细胞发生反应。发现该抗体也能与由非离子去污剂溶解的、具有不同HLA - DR特异性的细胞的膜糖蛋白发生反应:因此,引发抗体6148的肽可能代表了DR同种异体抗原的一个共同框架决定簇,该决定簇在淋巴母细胞表面是可及的。通过间接免疫荧光和荧光激活细胞分选分析证实了抗体6148与完整细胞结合的能力。通过51Cr释放测定确定,该抗体也能够介导抗体依赖性细胞毒性。